Also known as: ACVR2B-Fc
ACE-031, also known as ActRIIB-Fc, is a peptide classified under the category of anabolic and myostatin peptides. It is a soluble receptor for myostatin, a protein that inhibits muscle growth. By binding to myostatin, ACE-031 effectively reduces its activity, promoting muscle hypertrophy and increasing muscle mass.
This peptide has garnered interest in the field of muscle biology and therapeutic applications due to its potential to enhance muscle growth and strength. Research into ACE-031 focuses on its role in muscle development and its implications for conditions characterized by muscle wasting.
ACE-031 functions by acting as a decoy receptor for myostatin. When myostatin binds to its natural receptor, it signals the body to limit muscle growth. ACE-031 intercepts this signaling pathway, preventing myostatin from exerting its inhibitory effects on muscle cells.
By blocking myostatin, ACE-031 promotes muscle cell proliferation and differentiation, leading to increased muscle fiber size and overall muscle mass. This mechanism is particularly relevant in research focused on muscle regeneration and growth.
ACE-031 is a soluble myostatin receptor peptide that plays a crucial role in muscle growth by inhibiting myostatin activity. Its research applications span various fields, particularly in muscle regeneration and treatment of muscle-wasting conditions, highlighting its relevance in both clinical and athletic contexts.
Last updated: Feb 25, 2026